observed that loss of KMT2C activity in bladder cancer and others does not directly affect proliferation or viability but causes DNA repair defects and sensitizes cells to PARP inhibition by downregulation of genes involved in homologous repair of double-strand breaks (85). This evidence concerns the gene KMT2C and urinary bladder cancer.